HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

maltose-tri-O-methyl nordihydroguaiaretic acid

able to reverse the MDR phenotype of the tumor cells in a xenograft model system and combination therapy with M4N or maltose-M3N and paclitaxel was effective at inhibiting growth of these tumors in nude mice
Also Known As:
maltose-M3N
Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Lee, Yuan Chuan: 1 article (11/2006)
2. Huang, Ru Chih C: 1 article (11/2006)
3. Lin, Chien-Fu: 1 article (11/2006)
4. Chang, Chih-Chuan: 1 article (11/2006)
5. Liang, Yu-Chuan: 1 article (11/2006)
6. Mold, David E: 1 article (11/2006)
7. Klutz, Athena: 1 article (11/2006)
8. Hsu, Chuan-I: 1 article (11/2006)
9. Chou, Ting-Chao: 1 article (11/2006)

Related Diseases

1. Neoplasms (Cancer)

Related Drugs and Biologics

1. maltose-tri-O-methyl nordihydroguaiaretic acid
2. Paclitaxel (Taxol)

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)